Want to trade like Wall Street insiders? Start by watching what they DO, not what they SAY. How? TradeAlgo reveals the 3-Step process:
STEP #1: Check the dark pool alerts for irregular activity. STEP #2: Scan through each stock’s charts to spot any technical breakouts. STEP #3: Enter breakout trades with high-quality setups. The 3-Step process allows traders to shadow Smart Money and ride stocks’ breakouts.
AngioDynamics (ANGO) reported a loss of $0.10 per share on revenue of $75.71 million for the fiscal first quarter ended August 2025. The consensus estimate was a loss of $0.14 per share on revenue of $72.28 million. The company beat consensus estimates by 28.57% while revenue grew 12.18% on a year-over-year basis.
The company said it expects a fiscal 2026 loss of $0.33 to $0.23 per share on revenue of $308.0 million to $313.0 million. The company's previous guidance was a loss of $0.35 to $0.25 per share on revenue of $305.0 million to $310.0 million, and the current consensus estimate is a loss of $0.30 per share on revenue of $306.34 million for the year ending May 31, 2026.
“We had an outstanding first quarter as we continued to build off of the strong momentum created in fiscal 2025,” commented Jim Clemmer, President and Chief Executive Officer of AngioDynamics, Inc. “Our strategy to bring unique platform technologies to large, fast growing global markets has paid off as we reported our fourth quarter in a row of MedTech growth of over 20%. This continued performance, combined with our disciplined focus on operational excellence, is driving sustained profitable growth.”
AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.
In-line Guidance
Coursera Reaffirms
Coursera (COUR) said it continues to expect third quarter revenue of $188.0 million to $192.0 million and 2025 revenue of $738.0 million to $746.0 million. The current consensus revenue estimate is $190.4 million for the quarter ending September 30, 2025 and revenue of $743.8 million for the year ending December 31, 2025.
Coursera was launched in 2012 by two Stanford Computer Science professors, Andrew Ng and Daphne Koller, with a mission to provide universal access to world-class learning.
The Fed's September rate cut triggered euphoria followed by chaos, exactly as predicted. With unemployment hitting 4.3% and nearly 1 million phantom jobs erased from government records, traditional analysis is failing traders when they need it most.
Since 1991 — long before A.I. became mainstream — VantagePoint has been perfecting predictive algorithms through every market crash, boom, and black swan event.
Because this battle-tested system spots opportunities others miss.
The A.I. engine is flagging 3 exact entry points that traditional traders won't recognize until gains evaporate.
AngioDynamics (ANGO) reported a loss of $0.10 per share on revenue of $75.71 million for the fiscal first quarter ended August 2025. The consensus estimate was a loss of $0.14 per share on revenue of $72.28 million. The company beat consensus estimates by 28.57% while revenue grew 12.18% on a year-over-year basis.
Coursera (
